We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Builders FirstSource
BLDR
$7.83B
| $648K | 0.09% |
+57,494
| New | +$498K |
|
|
FRAN
377
DELISTED
Francesca's Holdings Corporation
FRAN
| $647K | 0.09% |
+2,815
| New | +$607K |
|
|
GBT
378
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $640K | 0.09% |
+40,343
| New | +$717K |
|
379
M/I Homes
MHO
$3.81B
| $639K | 0.09% |
+34,253
| New | +$616K |
|
|
ITCI
380
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $639K | 0.09% |
+22,968
| New | +$765K |
|
|
HSNI
381
DELISTED
HSN, Inc.
HSNI
| $639K | 0.09% |
12,210
-25,607
| -68% | -$1.27M |
|
382
Popular Inc
BPOP
$11B
| $633K | 0.09% |
+22,127
| New | +$580K |
|
383
Mistras Group
MG
$490M
| $624K | 0.09% |
25,198
+11,948
| +90% | +$264K |
|
|
FCB
384
DELISTED
FCB Financial Holdings, Inc.
FCB
| $622K | 0.09% |
+18,711
| New | +$596K |
|
385
Digi International
DGII
$2.52B
| $618K | 0.09% |
65,492
+4,934
| +8% | +$45K |
|
|
TRK
386
DELISTED
Speedway Motorsports, Inc.
TRK
| $618K | 0.09% |
31,170
-2,170
| -7% | -$40.1K |
|
|
CSH
387
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $613K | 0.09% |
+15,865
| New | +$517K |
|
|
LXFT
388
DELISTED
Luxoft Holding, Inc.
LXFT
| $611K | 0.09% |
11,111
-8,380
| -43% | -$504K |
|
389
MaxLinear
MXL
$5.73B
| $606K | 0.09% |
32,770
+13,722
| +72% | +$218K |
|
|
EPIQ
390
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $604K | 0.09% |
40,225
-120,787
| -75% | -$1.55M |
|
391
Chemed
CHE
$6.8B
| $603K | 0.09% |
+4,450
| New | +$601K |
|
392
United Fire Group
UFCS
$1.33B
| $603K | 0.09% |
+13,766
| New | +$542K |
|
393
Travere Therapeutics
TVTX
$5.29B
| $601K | 0.09% |
43,996
+5,526
| +14% | +$83.8K |
|
|
AAWW
394
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $601K | 0.09% |
+14,211
| New | +$532K |
|
395
HealthStream
HSTM
$816M
| $599K | 0.09% |
+27,104
| New | +$558K |
|
396
Pegasystems
PEGA
$4.85B
| $596K | 0.09% |
+46,928
| New | +$563K |
|
397
Federal Agricultural Mortgage
AGM
$2.28B
| $594K | 0.09% |
15,740
+3,562
| +29% | +$116K |
|
398
Tronox
TROX
$944M
| $593K | 0.09% |
92,878
+82,516
| +796% | +$366K |
|
|
PGNX
399
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $592K | 0.09% |
135,803
-262,480
| -66% | -$1.17M |
|
|
IPXL
400
DELISTED
Impax Laboratories, Inc.
IPXL
| $592K | 0.09% |
+18,483
| New | +$650K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.